CN Patent

CN102014956B — Psma结合配体-接头缀合物及其使用方法

Assigned to Purdue Research Foundation · Expires 2015-06-03 · 11y expired

What this patent protects

本文描述的是用于递送治疗剂、诊断剂和显像剂的前列腺特异性膜抗原(PSMA)结合缀合物。本文还描述的是包含其的药物组合物以及使用缀合物和组合物的方法。还描述的是用于制造缀合物和包含其的组合物的方法。

USPTO Abstract

本文描述的是用于递送治疗剂、诊断剂和显像剂的前列腺特异性膜抗原(PSMA)结合缀合物。本文还描述的是包含其的药物组合物以及使用缀合物和组合物的方法。还描述的是用于制造缀合物和包含其的组合物的方法。

Drugs covered by this patent

lutetium-lu-177-vipivotide-tetraxetan (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN)

Patent Metadata

Patent number: CN102014956B
Jurisdiction: CN
Classification: —
Expires: 2015-06-03
Drug substance claim: No
Drug product claim: No
Assignee: Purdue Research Foundation
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.